- Retraction Note
- Open access
- Published:
Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial
Clinical and Translational Allergy volume 10, Article number: 48 (2020)
The Original Article was published on 30 March 2015
Retraction Note to: Clin Transl Allergy (2015) 5(Suppl3):P30 https://doi.org/10.1186/2045-7022-5-S3-P30
The authors have retracted this poster abstract [1] because of concerns regarding the validity of the post-hoc analysis presented here. An independent statistical analysis has found that the post-hoc analysis used a very small sample, which means the results are not generalizable to the original sample included in the trial. Conclusions based on results from this restricted sample are therefore unreliable. The effects seen are unlikely to be due to the active intervention and instead might be due to residual confounding related to age of weaning.
All authors agree to this retraction.
Reference
Boyle R, Brown N, Chiang WC, Chien CM, Gold M, Hourihane J, Peake J, Quinn P, Rao R, Smith P, Tang M, Ziegler J, Warner J, et al. Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial. Clinical and Translational Allergy. 2015;5(3):P30. https://doi.org/10.1186/2045-7022-5-S3-P30.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Boyle, R., Brown, N., Chiang, W.C. et al. Retraction Note to: Partially hydrolysed, prebiotic supplemented whey formula for the prevention of allergic manifestations in high risk infants: a multicentre double-blind randomised controlled trial. Clin Transl Allergy 10, 48 (2020). https://doi.org/10.1186/s13601-020-00356-5
Published:
DOI: https://doi.org/10.1186/s13601-020-00356-5